Chief Technology Officer
Andrew Kraus brings nearly 30 years of business strategy, operational excellence, and technology innovation to his role as Chief Technology Officer at Clinical ink. With a strong focus on integrating business needs and requirements into IT planning and operations, Andrew is instrumental in driving our technology advancements. Prior to Clinical ink, Kraus served as Chief Operating Officer for World Care Clinical, a CRO providing centralized imaging and other services supporting clinical trials. He currently sits on the Board of Directors for Algorics, a specialized clinical data services company.
Previously, Kraus held executive roles at several clinical technology companies including COO at Bioclinica (now part of Clario); SVP Service, Strategy and Operations at Signant; and COO and Treasurer for the Cardiovascular Research Foundation. Kraus has deep knowledge of the clinical trial space, having co-founded Beacon Bioscience as CTO and overseen its growth into a global imaging and clinical event adjudication provider. The company was acquired by ICON plc, where he managed all of ICON’s imaging and data technology businesses.
Andrew earned a BSE and MSE in Bioengineering from the University of Pennsylvania.
Areas of Expertise
- Digital transformation and emerging technologies
- Interoperability standards and systems integration
- Data security and regulatory compliance